Navigation Links
State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report

than both the PA average of 46.9% and the national average of 43.8%

Charges for diabetes care in Pittsburgh is lower

Charges for the care of people with Type 2 diabetes are lower in Pittsburgh than the both the national and PA averages. The Report shows that the 2005 annual average for hospital inpatient charges for treating people with Type 2 Diabetes was $32,354, significantly lower than the national average of $39,401 that was significantly lower than the PA average of $54,795. The average annual office visit charges for treating people with Type 2 diabetes in Pittsburgh, $1,002, were also lower than the PA average of $1,289 and significantly lower than the national average of $3,266.

Quality of care shows positives

The quality of care indicators for patients with Type 2 diabetes, a major concern, pointed to positive signs for employers who want to ensure that their employees receive appropriate care. In addition to demographic and cost information, the Pittsburgh Type 2 Diabetes Report shows the percentage of people with diabetes receiving recommended services, such as for glucose, Hemoglobin A1C and cholesterol blood tests, as well as eye exams and urine tests for glucose. The percentages for these care indicators are higher in Pittsburgh compared to the national averages. For example, people with Type 2 diabetes in Pittsburgh who received a Hemoglobin A1C test (a key marker for managing diabetes) in 2005 was 77.0 percent compared to the national average of 74.1 percent. 87.2 percent of people with diabetes received the cholesterol test in Pittsburgh compared to the nationally average of 83.9 percent.

PBGH believes that the Pittsburgh Type 2 Diabetes Report for 2006 will help providers and employers continue to support efforts to manage the increasing prevalence, costs and quality of care provided to people with Type 2 diabetes. "PPG is committed to improving the health and wellness of our employees. This report provides bench
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Obama Statement on Bush Veto of Stem Cell Bill
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
5. Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University
6. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
9. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:7/23/2008)...nds Some Areas of the Body Have Greater Concentrat... 23 /PRNewswire-USNewswire/ -- Fat removed,from th...n was found to be,an excellent source of stem cell... areas of the body, reports a Brazilian-based stud...), the official medical journal of the,American So...
(Date:7/22/2008)...tralia, July 22 /- Followin... the Board of Progen,Pharmaceuticals Limited (ASX:...scontinued the PI-88 phase 3 study in liver cancer...lop its existing portfolio of compounds and,the co...pounds and,opportunities through Merger & Acquisit...
(Date:7/22/2008)...g to Discuss Development Plan Completed Successful...l/ -- Amarin Corporation,plc (NASDAQ: AMRN ) toda...icials at the U.S. Food and Drug Administration (F...01 for the treatment of,hypertriglyceridemia. Foll... to Phase 3 with AMR101 in hypertriglyceridemia., ...
(Date:7/22/2008)...llan Will Stress the Importance to Patients of Pas...al Pathway, RICHMOND, Va., July 22 /PRNewswire-Fi...per of follow-on biologics and biopharmaceuticals,...f Insmed, will present at a,Congressional briefing...cant need for establishing an approval pathway for...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 10496 1Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 10496 2Markets of biodiversity and equity in trade 3A An illusion 3F 2058 1Markets of biodiversity and equity in trade 3A An illusion 3F 2058 2Markets of biodiversity and equity in trade 3A An illusion 3F 2058 3American Journal of Disaster Medicine Accepted for Inclusion into The National Library of Medicines MEDLINE Database and may now be Accessed Through t 10495 1American Journal of Disaster Medicine Accepted for Inclusion into The National Library of Medicines MEDLINE Database and may now be Accessed Through t 10495 2Life 3AWIRE 28TM 29 to Provide Action Healthcare Management with Innovative Mobile Health Management Solution for Patients with Chronic Conditions 10492 1Life 3AWIRE 28TM 29 to Provide Action Healthcare Management with Innovative Mobile Health Management Solution for Patients with Chronic Conditions 10492 2
... /PRNewswire-FirstCall/ -- Iomai,Corporation today...Phase 1 trial of its patch-based needle-free influ...onference call and live,webcast will be held at 8:...ts. , Conference Call Details , To access the live... Eastern Time via phone, please dial 888-396-2356 ...
... 2007 - HepaLife Technologies, Inc.,(OTCBB:HPLF) (...entific presentation of its cell based PBS-1 techn...t the "Options for the,Control of Influenza VI Con... Canada., Entitled "High titer growth of human and...embryo cell line without the need for,exogenous pr...
Other Medicine Technology:Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 2HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 3HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 4HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 5
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
... cancer often results in radiation-induced damage ..., targeted over-expression of heat shock protein 2...by Lee et al., "Radioprotective effect of HSP25 on...ished in the November issue of The American Journa...
...ilities, Health Minister Anbumani Ramadoss has bla...//, which has so far taken toll of over 130 lives ...par for the CNN-IBN programme Devil's Advocate to ...Even though I don't want to shy away from my respo...
... scientists that plays a key role in advancing inf...chers// who feel this might be the breakthrough lo...ntestinal diseases such as Crohn’s disease and ulc...een implicated with many chronic illnesses associa...
...omen who thrive on a diet which is rich in helping...he like //which is highly refined energy food gain...women who conscientiously take a diet rich in fibe...ned food is easily broken down to simple sugar, gl...
Other Medicine News:Health News:Radioprotective effect of Heat Shock Proteins 2Health News:Ramadoss Blames State Governments for High Dengue Toll 2Health News:Ramadoss Blames State Governments for High Dengue Toll 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: